Project Details
石桥生物

天津石桥生物科技有限责任公司


由哈佛归国博士创立的生物技术高科技公司。公司以高水平重组蛋白质表达技术平台,致力于发展生物医药。公司拥有超级细胞增强因子技术。免疫、抗体治疗的发展火热,是行业大趋势。细胞的培养调节成分是这个行业中的关键配方技术,有较大的市场,并能够锁定收益环节。项目有较好的发展预期。

Related items
Unique concept emerging business model. It has a mobile body fluid in vitro diagnostics of key technologies (pending global patents); in this field is expected to become leader.
Globally patented technology, innovative drugs targeting anti-tumor protein-based immune stimulation, it is possible to create a new targeted cancer immunotherapy field.
A new immune biosensor research project. This project has received international PCT patent and is expected to lead to disruptive technological revolution.
湖北普罗金科技有限公司 创业工场孵化项目。 拥有领先技术的蛋白组学研发型企业。中科院“百人计划”人才领衔。
More Projects
Home
About Us
News
Information
Investment
Jobs
Contact
Incubation Project
Company Profile
Philosophy
Areas of concern
Business
Entrusted investment
 
Industry News
Industry Information
Investment Advantages
Principal investment
Talent Concept
Careers
Shenzhen Sangel Venture Capital Co.,Ltd
Address:Room 2401/2402, Shenzhen Bay VC&PE Builing, Nanshan District, Shenzhen,Guangdong Province, China 
Tel:0755-26069007
Fax:0755-26491800
Website:www.sangelvc.com

Copyright © 2008-2016 | All Rights Reserved | Shenzhen Sangel Venture Capital Co.,Ltd. | ICP:15012769